newsfilter
← Latest News
GlobeNewswire·

PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Update

– VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsules, gain FDA approval – – Company secured $71.4 million of gross proceeds in an underwritten public offering of common stock for the launch of VAZALORE – –